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l,SDifluoro-2,4-dinitrobenzene completely inhibits F,-ATPase when it is used at micromolar concentra- 
tions and the inhibitor/enzyme molar ratio is equal to 3. The inhibition can be reversed by dithiothreitol 
treatment. 7-Chloro4nitrobenzofurazan treatment of F,-ATPase does not prevent the reaction of the en- 
zyme with l,S-difluoro-2,4_dinitrobenzene. The l,S-difluoro-2,4-dinitrobenzene-induced inhibition is 
thought to be a result of the modification of a tyrosine residue with pK 9.1. 
Mitochondrial F,-ATPase Tyrosine modification 
1. INTRODUCTION 
Mitochondrial Fi-ATPase has a molecular mass 
of approx. 380 kDa and a complex subunit struc- 
ture (review [l]). But surprisingly enough, of all 
the numerous amino acid residues of this enzyme 
there are only a few that react with low concentra- 
tions of the reagents modifying the protein func- 
tional groups. It is precisely these amino acid 
residues that take part in the ATPase activity of 
Fi-ATPase. Thus, N-cyclohexyl-N’-&(Cmethyl- 
morpholine)ethylcarbodiimide modifies one car- 
boxy1 group in Fi-ATPase, and this causes the 
complete inhibition of its ATPase activity [2]. 
N,N’ -Dicyclohexylcarbodiimide behaves in a 
similar manner, although the other carboxyl group 
in Fi-ATPase probably serves as the target of the 
attack in this case [3]. 7-Chloro-4-nitrobenzofura- 
zan reacts with one tyrosine residue in Fi-ATPase. 
This reaction is also accompanied by the inactiva- 
tion of Fi-ATPase [4]. Another tyrosine residue 
controlling the ATPase activity was modified with 
the ATP analogs e in the work of Esch and Allison 
* To whom correspondence should be addressed 
[5]. Inhibition of Fi-ATPase also occurs as a result 
of the modification of arginine residues with 
phenylglyoxal [6,7], and lysine residues with 
pyridoxal phosphate [8,9] and with 2,4-dinitro- 
fluorobenzene [ 10,111. 
Here, we have studied the reaction of Fi-ATPase 
with 1,5-difluoro-2,4_dinitrobenzene. This reagent, 
which is briefly mentioned by Andrews and Allison 
[ 1 l] as an inhibitor of mitochondrial ATPase, sup- 
presses Fi-ATPase activity at micromolar concen- 
trations. Complete inhibition of the Fi-ATPase is 
achieved when the molar ratio 1,5-difluoro-2,4- 
dinitrobenzene/Fi-ATPase is equal to 3. 
2. MATERIALS AND METHODS 
1,5-Difluoro-2,Cdinitrobenzene and ‘I-chloro- 
4-nitrobenzofurazan from Fluka, dithiothreitol, 
Tris, Mops, and SDS from Sigma and ATP from 
Reanal were used. 
The Fi-ATPase was prepared from beef heart 
mitochondria according to Knowles and Penefsky 
[12]. Aliquots of the enzyme were desalinated, 
using Sephadex G-50 (fine) columns in 10 mM 
Mops-NaOH buffer, pH 7.5, containing 1 mM 
EDTA and 0.25 M sucrose [ 131. Desalinated 
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Fr-ATPase was stored in liquid nitrogen. Prior to 
the experiment, the enzyme preparations were 
thawed out on a water bath at 37°C. 
The ATPase activity was measured in 1 ml of a 
medium containing 25 mM Tris-HCl, 2 mM 
MgS04, 2 mM ATP, pH 8.4. After 3 min, the 
reaction was stopped by the addition of 0.5 ml of 
3.0% SDS and 10 mM EDTA. Inorganic 
phosphate concentrations were measured accord- 
ing to [14]. Standard preparations of the enzyme 
have an ATPase activity of 70-80 pmol * min-’ . 
mg-‘. 
The protein concentration was measured ac- 
cording to Lowry et al. [ 151. 
All the experiments to modify Fr-ATPase were 
carried out at 25°C in the dark. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the time course of the inhibition of 
Fig. 1. The inhibition of Fr-ATPase by the consecutive 
equimolar addition of l ,S-difluoro-2,4_dinitrobenzene. 
Fr-ATPase (1.9 mg/ml, 5.5 PM) was dissolved in a 
solution containing 80 mM triethanolamine, pH 8.5, 
1 mM EDTA and 0.25 M sucrose. The arrows indicate 
when the methanol solution of 1.5difluoro-2,4-dinitro- 
benzene was added to this mixture. In every case, 
inhibitor additions equimolar to Ft-ATPase were made. 
The molar ratio inhibitor/Ft-ATPase was equal to 1 
(curve l), 2 (curve 2), and 3 (curve 3). Aliquots of the 
reaction mixture were taken after the time intervals 
indicated to measure the ATPase activity. In the control 
experiments (section of the curves which are parallel to 
the abscissa), only 1 (curve 1) or 2 (curve 2) additions of 
1,5-difluoro-2,4_dinitrobenzene were made. Curve 4: 
Fr-ATPase was incubated in the same mixture, but 
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Fig.2. The kinetics of the inhibition of Fr-ATPase by 
different concentrations of 1,5-difluoro-2,4-dinitro- 
benzene. For conditions, see the legend to fig.1. The 
concentration of Fi-ATPase was 0.4 mg/ml; concentra- 
tion of 1,5-difluoro-2,4_dinitrobenzene - 10 pM (curve 
l), 15 PM (curve 2), 20 pM (curve 3), 25 PM (curve 4), 
30 PM (curve 5), 50 PM (curve 6) and 80 ,uM (curve 7). 
Inset: determination of the order for the reaction of 
without the inhibitor. Fr-ATPase with 1,5-difluoro-2,4_dinitrobenzene. 
Fr-ATPase activity by 1,5-difluoro-2,4-dinitro- 
benzene. It follows from the results obtained that 
the micromolar concentrations of 1,5-difluoro- 
2,4_dinitrobenzene readily slow down the ATPase 
activity, and complete inhibition is achieved when 
the inhibitor/ATPase ratio is equal to 3. 
Low concentrations of the inhibitor, the short 
duration of the reaction and also the fact that the 
inhibition is completed at a small molar excess of 
1,5-difluoro-2,6dinitrobenzene all reveal that 
1,5-difluoro-2,4_dinitrobenzene is one of the most, 
if not the most, powerful of the known inhibitors 
of Fr-ATPase. 
Fig.2 shows the kinetics of the inhibition of 
Fr-ATPase at a great molar excess of 
1,5-difluoro-2,4_dinitrobenzene. It follows from 
the results obtained that the inhibition occurs as a 
pseudomonomolecular eaction, i.e. (i) 1,5-di- 
fluoro-2,4_dinitrobenzene reacts with Fr-ATPase 
without the step of specific non-covalent binding 
to the enzyme and (ii) the inhibition is a result of 
the reaction of 1,5-difluoro-2,6dinitrobenzene 
with one amino acid residue of Fr-ATPase. 
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The chemical properties of 1,5-difluoro-2,4- 
dinitrobenzene and the data on the chemical nature 
of the groups controlling Fr-ATPase activity 
[4,5,8-lo] indicate that the inhibition is caused by 
the reaction of this inhibitor with a tyrosine or 
lysine residue. Cysteine, the other candidate for 
the reaction with 1,5-difluoro-2,4_dinitrobenzene, 
was not found in the composition of the fl- 
subunits, which bear the ATPase active site [la]. 
So, cysteine modification with 1,5-difluoro-2,4- 
dinitrobenzene cannot be the reason for enzyme in- 
hibition. Histidine modification also seems to be 
unlikely due to the pH dependence of the reaction 
(see fig.4) and also because the reagents specific to 
histidine do not inhibit the ATPase reaction [8]. 
The addition of 100 mM dithiothreitol to Fr- 
ATPase preincubated with 80 pM 1,5-difluoro- 
2,4_dinitrobenzene for 4 min and having 55% of 
the initial activity, leads to the almost complete 
restoration of its ATPase activity. This result 
testifies to the fact that 1,5-difluoro-2,4-dinitro- 
benzene modifies a tyrosine residue in Fr-ATPase 
since dinitrobenzene derivatives of tyrosine react 
with dithiothreitol with the restoration of free 
tyrosine [17] and, on the other hand, the 1,5- 
difluoro-2,6dinitrobenzene reaction with a lysine 
residue could not be reversed by dithiothreitol. 
Another well known inhibitor of Fr-ATPase that 
reacts with tyrosine is 7-chloro-4-nitrobenzofura- 
zan. Dithiothreitol treatment of Fr-ATPase 
modified with this inhibitor also leads to the 
restoration of ATPase activity [4]. We therefore 
tried to determine whether 1,5-difluoro-2,4- 
dinitrobenzene and 7-chloro-4-nitrobenzofurazan 
react with the same tyrosine residue in Fr-ATPase. 
Fr-ATPase was consecutively treated with 
7-chloro-4-nitrobenzofurazan and 1,5-difluoro- 
2,4_dinitrobenzene. The enzyme modified in this 
way was then treated for 5 min with 5 mM 
dithiothreitol. The time of incubation with 
dithiothreitol and its concentration were sufficient 
to reactivate Fr-ATPase treated with 7-chloro-4- 
nitrobenzofurazan (on the other hand, such dithio- 
threitol treatment was too mild to cause reversion 
of the 1,5-difluoro-2,4-dinitrobenzene-induced in- 
hibition). The control preparation of Fr-ATPase 
was subjected to the same treatment, excluding 
7-chloro-4-nitrobenzofurazan. The results of these 
experiments are given in fig.3. Similar slopes of the 
curves in fig.3 testify to the fact that a control 
Fig.3. 7-Chloro-4-nitrobenzofurazan treatment of 
Fr-ATPase does not prevent the reaction of this enzyme 
with 1,5-difluoro-2,4_dinitrobenzene. Fr-ATPase (5 
mg/ml) was incubated for 40 min in a reaction mixture 
containing 50 mM Mops-NaOH, pH 7.5, 1 mM EDTA, 
0.25 M sucrose and 1OOpM 7-chloro-4-nitrobenzo- 
furazan. The modified Fr-ATPase containing less than 
10% of the initial activity was separated from the re- 
action mixture by Penefsky’s method [13] (see section 2). 
The control preparation of Fr-ATPase was treated in the 
same way but without 7-chloro-4-nitrobenzofurazan. To 
both Fr-ATPase preparations (final protein concentra- 
tion 1 mg/ml) triethanolamine was added up to a con- 
centration of 80 mM, pH 8.5, and then the protein 
solutions were incubated with 15 PM 1,5-difluoro-2,4- 
dinitrobenzene. After the time intervals indicated, 
aliquots of the reaction mixture were taken and in- 
cubated for 5 min with 5 mM dithiothreitol. Then the 
ATPase activity of these enzyme aliquots was measured. 
Curve 1, control preparation of Fl-ATPase; curve 2, 
Fl-ATPase pretreated with 7-chloro-4-nitrobenzo- 
furazan. 
preparation of Fr-ATPase and Fr-ATPase treated 
with 7-chloro-4nitrobenzofurazan reacts with 
1,5-difluoro-2,4_dinitrobenzene at the same rate. 
Thus, there is no competition between these in- 
hibitors for Fr-ATPase, i.e. 1,5-difluoro-2,4-dini- 
trobenzene modifies another amino acid residue 
than does 7-chloro-4-nitrobenzofurazan. 
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At saturating concentrations, ATP and ADP 
only partially protect Fr-ATPase from the 
1,5-difluoro-2,4-dinitrobenzene-induced inhibi- 
tion. For example, 0.5 mM ATP decreases the rate 
of inhibition of Fi-ATPase by 1,5-difluoro-2,4- 
dinitrobenzene (15 PM) 2.7-fold. Thus, the ques- 
tion remains open as to whether the group reacting 
with this inhibitor is located at or outside the active 
site of the Fi-ATPase. 
Fig.4 shows the pH dependence of the rate con- 
stant of Fi-ATPase inhibition by 1,5-difluoro- 
2,Cdinitrobenzene in the absence (curve 1) and 
presence (curve 2) of ATP. An analysis of these 
curves using a computer program revealed that in 
both cases the pK of the group reacting with 1,5- 
difluoro-2,Cdinitrobenzene is equal to 9.1 + 0.1. 
It follows from these data that the protective effect 
of ATP is not caused by the ATP-dependent 
change in the pK of the group reacting with 
1,5-difluoro-2,4_dinitrobenzene. 
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Fig.4. The pH dependence of Fr-ATPase inhibition by 
1,5-difluoro-2,4_dinitrobenzene. /cobs values of the 
reaction were determined as shown in fig.2. Conditions 
as in fig.2 except that the inhibitor concentration was 
15 pM and for the buffer mixtures of triethanolamine 
and Mops were used. In the case of curve 2, incubations 
of Fi-ATPase with 1 $difluoro-2,4-dinitrobenzene were 
carried out in the presence of 0.5 mM ATP. 
Our results indicate that 1,5-difluoro-2,4- 
dinitrobenzene is a very powerful inhibitor of 
Fi-ATPase. The inhibition is probably caused by 
the modification of a tyrosine residue with pK 9.1, 
and this tyrosine residue is not the same one that 
reacts with 7-chloro-4-nitrobenzofurazan. 
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